Celldex Therapeutics , Inc. (NASDAQ:CLDX), a biopharmaceutical company with a market capitalization of $1.6 billion focused on developing innovative therapies for challenging diseases, has been making ...

IBM, which already had at least 270,000 square feet at the 26-story Midtown South office building, signed a 15-year lease and ...

The FDA’s decision marks J&J's Spravato as the first monotherapy for adults with treatment-resistant depression.

SAN DIEGO, CA - Dermata Therapeutics , Inc. (NASDAQ:DRMA) and Revance Therapeutics, Inc. (Nasdaq: NASDAQ:RVNC), two ...

NDAQ:HOTH) Hoth Therapeutics Expands Intellectual Property Portfolio with Acquisition of New Patent Applications ...

BTIG analyst Julian Harrison has maintained their bullish stance on SYRE stock, giving a Buy rating on January 14.Invest with Confidence: ...

Lil Gator Game dropped at the tail end of 2022 and has stood the test of time since as one of the coziest indie games ...

Avacta Therapeutics has reported outcomes from the Phase Ia trial of AVA6000, a drug candidate for solid tumours.

Omvoh’s label expansion is important progress for Eli Lilly as it works to diversify its portfolio beyond obesity, according ...

CTIM-76 Phase 1 trial focused on CLDN6-positive gynecologic and testicular cancers Trial marks key milestone in driving ...

Turning to 2025 guidance, Lilly noted that new medicines and new uses of existing medicines, expansion of production, and ...

C4 Therapeutics (CCCC) announced its anticipated 2025 milestones as it continues its evolution into becoming a fully integrated biotechnology ...